Eli Lilly & Co earnings were $25.3B for the trailing 12 months ending Mar 31, 2026, with 128.4% growth year over year. The latest LLY earnings report on Mar 31, 2026 announced Q1 2026 earnings of $7.4B, up 11.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LLY reported annual earnings of $20.6B, with 94.9% growth. The next LLY earnings date is Aug 5, 2026.
LLY past earnings growth
How has LLY's earnings growth performed historically?
On LLY's earnings call on Invalid Date, Eli Lilly & Co (NYSE: LLY) reported Q1 2026 earnings per share (EPS) of $8.27, up 169.38% year over year. Total LLY earnings for the quarter were $7.40 billion. In the same quarter last year, Eli Lilly & Co's earnings per share (EPS) was $3.07.
The next LLY earnings call is Invalid Date. Add LLY to your watchlist to be reminded of Eli Lilly & Co's next earnings date.
Is Eli Lilly & Co profitable or losing money?
As of the last Eli Lilly & Co earnings report, Eli Lilly & Co is currently profitable. Eli Lilly & Co's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $25.28 billion, a 127.59% increase year over year.
What was LLY's earnings growth in the past year?
As of Eli Lilly & Co's earnings date in Invalid Date, Eli Lilly & Co's earnings has grown 128.44% year over year. This is 85.59 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 42.85%. LLY earnings in the past year totalled $25.28 billion.
What are Eli Lilly & Co's earnings expectations?
The current EPS estimate for Eli Lilly & Co's earnings report in Invalid Date is $8.81.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.